NEWAMSTERDAM PHARMA COMPANY

Ticker: NAMS CUSIP: N62509109 Class: Stock

Slate Path Capital LP's Holding History (CIK: 0001559706)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 319,000 Value ($000) $11,191 Avg Close $36.39 Range $28.19 - $42.00

Q3 2025

Shares 319,000 Value ($000) $9,072 Avg Close $23.97 Range $17.97 - $28.91

Q2 2025

Shares 319,000 Value ($000) $5,777 Avg Close $18.24 Range $14.06 - $22.25

Q1 2025

Shares 319,000 Value ($000) $6,530 Avg Close $22.23 Range $17.18 - $26.80

Q4 2024

Shares 319,000 Value ($000) $8,198 Avg Close $21.24 Range $15.51 - $27.29

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	319,000	$11,191	$36.39	$28.19 - $42.00
Q3 2025	319,000	$9,072	$23.97	$17.97 - $28.91
Q2 2025	319,000	$5,777	$18.24	$14.06 - $22.25
Q1 2025	319,000	$6,530	$22.23	$17.18 - $26.80
Q4 2024	319,000	$8,198	$21.24	$15.51 - $27.29